| Trial ID: | L1845 |
| Source ID: | NCT00674466
|
| Associated Drug: |
1.5 Mg Or 2.0 Mg Cjc-1134-Pc
|
| Title: |
A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00674466/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: 1.5 mg or 2.0 mg CJC-1134-PC|DRUG: Placebo
|
| Outcome Measures: |
Primary: Reduction of HbA1c From Baseline, Change from baseline, Screening and Day 85 | Secondary: Reduction in Fasting Plasma Glucose From Baseline, Change from baseline, Screening and Day 85|Reduction in Fasting Body Weight From Baseline, Change from baseline, Screening and Day 85
|
| Sponsor/Collaborators: |
Sponsor: ConjuChem
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
90
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-03
|
| Completion Date: |
2008-11
|
| Results First Posted: |
2017-06-02
|
| Last Update Posted: |
2017-06-02
|
| Locations: |
Maggie Wang, Montreal, Quebec, H2X 3Y8, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00674466
|
